DLBS1033 for Acute Ischemic Stroke Patients "ADDLIST"


Phase 2/3 Results N/A

Summary of Purpose

This is a prospective, randomized, double-blind, and controlled clinical study to investigate the effects of DLBS1033 in conjunction with standard therapy compared to standard therapy alone in acute ischemic stroke patients. It is hypothesized that the improvement in functional outcomes as measured by NIHSS and BI as well as the improvement in haemostatic parameters as measured by thrombocyte aggregation test...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 24 November 2017.

1 Oct 2014 7 May 2014 1 Nov 2018 1 Dec 2018 1 Nov 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment